# Atezolizumab

## Tecentriq inj 1200mg-20mL

*藥物代碼*：ITEC

*給藥途徑*：I

*用法用量*：

Administer as IV infusion with initial dose over 60 min. If 1st dose is tolerated, all subsequent infusions may be administered over 30 min. Monotherapy 1,200 mg by IV infusion every 3 wk. Combination therapy: Non-squamous NSCLC In combination w/ bevacizumab, paclitaxel, & carboplatin: 1,200 mg by IV infusion, followed by bevacizumab, paclitaxel, & then carboplatin every 3 wk for 4 or 6 cycles during induction phase, then, followed by maintenance phase w/o chemotherapy in which 1,200 mg Tecentriq followed by bevazicumab, is administered by IV infusion every 3 wk. TNBC In combination w/ nab-paclitaxel: 840 mg by IV infusion, followed by 100 mg/m2 nab-paclitaxel. For each 28-day cycle Tecentriq is administered on days 1 & 15, & nab-paclitaxel is administered on days 1, 8 & 15.

